Literature DB >> 17311684

The concept of recovery in major depression.

Giovanni A Fava, Chiara Ruini, Carlotta Belaise.   

Abstract

BACKGROUND: There is increasing literature on the unsatisfactory degree of remission that current therapeutic strategies yield in unipolar depression. The aims of this review were to survey the available literature on residual symptoms of depression, to introduce new targets for therapy and to outline a more stringent definition of recovery.
METHOD: Studies were identified by using MEDLINE (English language articles published from 1967 to June 2006; keywords: recovery, remission, residual symptoms, sequential treatment, drugs and psychotherapy, related to depressive disorder and depression) and a manual search of the literature and Index Medicus for the years 1960-2006.
RESULTS: Most patients report residual symptoms despite apparently successful treatment. Residual symptoms upon remission have a strong prognostic value. There appears to be a relationship between residual and prodromal symptomatology. The concept of recovery should involve psychological well-being.
CONCLUSIONS: Appraisal of subclinical symptomatology in depression has important implications for pathophysiological models of disease and relapse prevention. New therapeutic strategies for improving the level of remission, such as treatment on residual symptoms that progress to become prodromes of relapse, may yield more lasting benefits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311684     DOI: 10.1017/S0033291706008981

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  45 in total

1.  The prognostic significance of subsyndromal symptoms emerging after remission of late-life depression.

Authors:  D N Kiosses; G S Alexopoulos
Journal:  Psychol Med       Date:  2012-05-21       Impact factor: 7.723

2.  The mental health clinic: a new model.

Authors:  Giovanni A Fava; Seugn K Park; Steven L Dubovsky
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

3.  Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  J Affect Disord       Date:  2016-04-13       Impact factor: 4.839

Review 4.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

5.  A comprehensive model of predictors of persistence and recurrence in adults with major depression: Results from a national 3-year prospective study.

Authors:  Nicolas Hoertel; Carlos Blanco; Maria A Oquendo; Melanie M Wall; Mark Olfson; Bruno Falissard; Silvia Franco; Hugo Peyre; Cédric Lemogne; Frédéric Limosin
Journal:  J Psychiatr Res       Date:  2017-07-22       Impact factor: 4.791

6.  Mindful mood balance: a case report of Web-based treatment of residual depressive symptoms.

Authors:  Jennifer Felder; Sona Dimidjian; Arne Beck; Jennifer M Boggs; Zindel Segal
Journal:  Perm J       Date:  2014-08-18

7.  Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.

Authors:  Shawn M McClintock; Mustafa M Husain; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Madhukar H Trivedi; Ian Cook; David Morris; Diane Warden; Augustus John Rush
Journal:  J Clin Psychopharmacol       Date:  2011-04       Impact factor: 3.153

Review 8.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 9.  Psychological well-being revisited: advances in the science and practice of eudaimonia.

Authors:  Carol D Ryff
Journal:  Psychother Psychosom       Date:  2013-11-19       Impact factor: 17.659

Review 10.  Intrusive images in psychological disorders: characteristics, neural mechanisms, and treatment implications.

Authors:  Chris R Brewin; James D Gregory; Michelle Lipton; Neil Burgess
Journal:  Psychol Rev       Date:  2010-01       Impact factor: 8.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.